PURPOSE: To investigate the clinical implications of a variable relative biological effectiveness (RBE) on proton dose fractionation. Using acute exposures, the current clinical adoption of a generic, constant cell killing RBE has been shown to underestimate the effect of the sharp increase in linear energy transfer (LET) in the distal regions of the spread-out Bragg peak (SOBP). However, experimental data for the impact of dose fractionation in such scenarios are still limited. METHODS AND MATERIALS: Human fibroblasts (AG01522) at 4 key depth positions on a clinical SOBP of maximum energy 219.65 MeV were subjected to various fractionation regimens with an interfraction period of 24 hours at Proton Therapy Center in Prague, Czech Republic. Cell killing RBE variations were measured using standard clonogenic assays and were further validated using Monte Carlo simulations and parameterized using a linear quadratic formalism. RESULTS: Significant variations in the cell killing RBE for fractionated exposures along the proton dose profile were observed. RBE increased sharply toward the distal position, corresponding to a reduction in cell sparing effectiveness of fractionated proton exposures at higher LET. The effect was more pronounced at smaller doses per fraction. Experimental survival fractions were adequately predicted using a linear quadratic formalism assuming full repair between fractions. Data were also used to validate a parameterized variable RBE model based on linear α parameter response with LET that showed considerable deviations from clinically predicted isoeffective fractionation regimens. CONCLUSIONS: The RBE-weighted absorbed dose calculated using the clinically adopted generic RBE of 1.1 significantly underestimates the biological effective dose from variable RBE, particularly in fractionation regimens with low doses per fraction. Coupled with an increase in effective range in fractionated exposures, our study provides an RBE dataset that can be used by the modeling community for the optimization of fractionated proton therapy.

Centre for Cancer Research and Cell Biology Queen's University Belfast UK

Department of Radiation Dosimetry Nuclear Physics Institute CAS Prague Czech Republic

Department of Radiation Dosimetry Nuclear Physics Institute CAS Prague Czech Republic; Proton Therapy Center Czech Prague Czech Republic; Department of Dosimetry and Application of Ionizing Radiation Faculty of Nuclear Sciences and Physical Engineering Czech Technical University Prague Prague Czech Republic

Proton Therapy Center Czech Prague Czech Republic

Radiation Dosimetry National Physical Laboratory Teddington UK

See more in PubMed

Suit H.D., Goitein M., Munzenrider J. Increased efficacy of radiation therapy by use of proton beam. Strahlenther Onkol. 1990;166:40–44. PubMed

Karger C.P., Jäkel O. Aktueller Stand und neue Entwicklungen in der Ionentherapie. Strahlenther Onkol. 2007;183:295–300. PubMed

Fokas E., Kraft G., An H. Ion beam radiobiology and cancer: Time to update ourselves. Biochim Biophys Acta. 2009;1796:216–229. PubMed

Weber U., Kraft G. Design and construction of a ripple filter for a smoothed depth dose distribution in conformal particle therapy. Phys Med Biol. 1999;44:2765–2775. PubMed

Loeffler J.S., Durante M. Charged particle therapy: Optimization, challenges and future directions. Nat Rev Clin Oncol. 2013;10:411–424. PubMed

Goodhead D.T. Energy deposition stochastics and track structure: What about the target? Radiat Prot Dosimetry. 2006;122:3–15. PubMed

Paganetti H., Niemierko A., Ancukiewicz M. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 2002;53:407–421. PubMed

Levin W.P., Kooy H., Loeffler J.S. Proton beam therapy. Br J Cancer. 2005;93:849–854. PubMed PMC

Prescribing, recording, and reporting proton-beam therapy. J ICRU. 2007;7:NP.

International Atomic Energy Agency. International Commission on Radiation Units and Measurements (ICRU) 2008. Relative biological effectiveness in ion beam therapy; pp. 1–165.

Brahme A. Development of radiation therapy optimization. Acta Oncol. 2000;39:579–595. PubMed

Chaudhary P., Marshall T.I., Perozziello F.M. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: A preclinical assessment. Int J Radiat Oncol Biol Phys. 2014;90:27–35. PubMed

Guan F., Bronk L., Titt U. Spatial mapping of the biologic effectiveness of scanned particle beams: Towards biologically optimized particle therapy. Sci Rep. 2015;5:9850. PubMed PMC

Calugaru V., Nauraye C., Noël G. Radiobiological characterization of two therapeutic proton beams with different initial energy spectra used at the Institut Curie Proton Therapy Center in Orsay. Int J Radiat Oncol Biol Phys. 2011;81:1136–1143. PubMed

Paganetti H. Relative biological effectiveness (RBE) values for proton beam therapy: Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol. 2014;59:R419–R472. PubMed

Mohan R., Mahajan A., Minsky B.D. New strategies in radiation therapy: Exploiting the full potential of protons. Clin Cancer Res. 2013;19:6338–6343. PubMed PMC

Dasu A., Toma-Dasu I. Impact of variable RBE on proton fractionation. Med Phys. 2013;40:011705. PubMed

Habl G., Hatiboglu G., Edler L. Ion prostate irradiation (IPI): A pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique. BMC Cancer. 2014;14:202. PubMed PMC

Newhauser W., Zhang R., Jones T. Reducing the cost of proton radiation therapy: The feasibility of a streamlined treatment technique for prostate cancer. Cancers (Basel) 2015;7:688–705. PubMed PMC

Wang Y., Efstathiou J.A., Lu H.M. Hypofractionated proton therapy for prostate cancer: Dose delivery uncertainty due to interfractional motion. Med Phys. 2013;40:071714. PubMed PMC

Wilkens J.J., Oelfke U. A phenomenological model for the relative biological effectiveness in therapeutic proton beams. Phys Med Biol. 2004;49:2811–2825. PubMed

Belli M., Bettega D., Calzolari P. Inactivation of human normal and tumour cells irradiated with low energy protons. Int J Radiat Biol. 2000;76:831–839. PubMed

Robertson J.B., Williams J.R., Schmidt R.A. Radiobiological studies of a high-energy modulated proton beam utilizing cultured mammalian cells. Cancer. 1975;35:1664–1677. PubMed

Courdi A., Brassart N., Hérault J. The depth-dependent radiation response of human melanoma cells exposed to 65 MeV protons. Br J Radiol. 1994;67:800–804. PubMed

Gueulette J., Böhm L., Slabbert J.P. Proton relative biological effectiveness (RBE) for survival in mice after thoracic irradiation with fractionated doses. Int J Radiat Oncol Biol Phys. 2000;47:1051–1058. PubMed

Gueulette J., Slabbert J.P., Böhm L. Proton RBE for early intestinal tolerance in mice after fractionated irradiation. Radiother Oncol. 2001;61:177–184. PubMed

Friedrich T., Scholz U., Elsässer T. Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation. J Radiat Res. 2013;54:494–514. PubMed PMC

Britten R.A., Nazaryan V., Davis L.K. Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam. Radiat Res. 2013;179:21–28. PubMed

Wedenberg M., Lind B.K., Hårdemark B. A model for the relative biological effectiveness of protons: The tissue specific parameter α/β of photons is a predictor for the sensitivity to LET changes. Acta Oncol. 2013;52:580–588. PubMed

Brenner D.J. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol. 2008;18:234–239. PubMed PMC

Chaudhary P., Marshall T.I., Currell F.J. Variations in the processing of DNA double-strand breaks along 60-MeV therapeutic proton beams. Int J Radiat Oncol Biol Phys. 2016;95:86–94. PubMed PMC

Antonelli F., Bettega D., Calzolari P. Inactivation of human cells exposed to fractionated doses of low energy protons: Relationship between cell sensitivity and recovery efficiency. J Radiat Res. 2001;42:347–359. PubMed

Development of a portable hypoxia chamber for ultra-high dose rate laser-driven proton radiobiology applications